• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4640408)   Today's Articles (187)   Subscriber (50351)
For: Storch GA. Humanized monoclonal antibody for prevention of respiratory syncytial virus infection. Pediatrics 1998;102:648-51. [PMID: 9738192 DOI: 10.1542/peds.102.3.648] [Citation(s) in RCA: 45] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]  Open
Number Cited by Other Article(s)
1
Noor A, Krilov LR. A Historical Perspective on Respiratory Syncytial Virus Prevention: A Journey Spanning Over Half a Century From the Setback of an Inactive Vaccine Candidate to the Success of Passive Immunization Strategy. J Pediatric Infect Dis Soc 2024;13:S103-S109. [PMID: 38577737 DOI: 10.1093/jpids/piae027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/06/2024] [Accepted: 04/03/2024] [Indexed: 04/06/2024]
2
A Candidate Therapeutic Monoclonal Antibody Inhibits Both HRSV and HMPV Replication in Mice. Biomedicines 2022;10:biomedicines10102516. [PMID: 36289776 PMCID: PMC9599547 DOI: 10.3390/biomedicines10102516] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2022] [Revised: 10/05/2022] [Accepted: 10/06/2022] [Indexed: 11/16/2022]  Open
3
Smith TRF, Schultheis K, Broderick KE. Nucleic acid-based vaccines targeting respiratory syncytial virus: Delivering the goods. Hum Vaccin Immunother 2018;13:2626-2629. [PMID: 28881156 PMCID: PMC5703370 DOI: 10.1080/21645515.2017.1363134] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]  Open
4
Ruzin A, Pastula ST, Levin-Sparenberg E, Jiang X, Fryzek J, Tovchigrechko A, Lu B, Qi Y, Liu H, Jin H, Yu L, Hackett J, Villafana T, Esser MT. Characterization of circulating RSV strains among subjects in the OUTSMART-RSV surveillance program during the 2016-17 winter viral season in the United States. PLoS One 2018;13:e0200319. [PMID: 30040837 PMCID: PMC6057637 DOI: 10.1371/journal.pone.0200319] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2018] [Accepted: 06/22/2018] [Indexed: 01/10/2023]  Open
5
Liu PC, Chen CA, Chen CM, Yen CH, Lee MH, Chuang CK, Tu CF, Su BL. Application of xenogeneic anti-canine distemper virus antibodies in treatment of canine distemper puppies. J Small Anim Pract 2016;57:626-630. [PMID: 27726133 DOI: 10.1111/jsap.12557] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2016] [Revised: 07/10/2016] [Accepted: 07/31/2016] [Indexed: 11/28/2022]
6
Swett-Tapia C, Bogaert L, de Jong P, van Hoek V, Schouten T, Damen I, Spek D, Wanningen P, Radošević K, Widjojoatmodjo MN, Zahn R, Custers J, Roy S. Recombinant measles virus incorporating heterologous viral membrane proteins for use as vaccines. J Gen Virol 2016;97:2117-2128. [PMID: 27311834 DOI: 10.1099/jgv.0.000523] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]  Open
7
Detection and measurement of staphylococcal enterotoxin-like K (SEl-K) secretion by Staphylococcus aureus clinical isolates. J Clin Microbiol 2014;52:2536-43. [PMID: 24808237 DOI: 10.1128/jcm.00387-14] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]  Open
8
Zeitlin L, Bohorov O, Bohorova N, Hiatt A, Kim DH, Pauly MH, Velasco J, Whaley KJ, Barnard DL, Bates JT, Crowe JE, Piedra PA, Gilbert BE. Prophylactic and therapeutic testing of Nicotiana-derived RSV-neutralizing human monoclonal antibodies in the cotton rat model. MAbs 2013;5:263-9. [PMID: 23396091 PMCID: PMC3893236 DOI: 10.4161/mabs.23281] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2012] [Revised: 12/10/2012] [Accepted: 12/14/2012] [Indexed: 01/27/2023]  Open
9
Monoclonal antibodies based on hybridoma technology. Pharm Pat Anal 2013;2:249-63. [DOI: 10.4155/ppa.13.2] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
10
Stiehm ER, Keller MA. Passive immunization. Vaccines (Basel) 2013. [DOI: 10.1016/b978-1-4557-0090-5.00001-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]  Open
11
Ding L, Azam M, Lin YH, Sheridan J, Wei S, Gupta G, Singh RK, Pauling MH, Chu W, Tran A, Yu NX, Hu J, Wang W, Long H, Xiang D, Zhu L, Hua SB. Generation of high-affinity fully human anti-interleukin-8 antibodies from its cDNA by two-hybrid screening and affinity maturation in yeast. Protein Sci 2010;19:1957-66. [PMID: 20718039 DOI: 10.1002/pro.484] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
12
An Z. Monoclonal antibodies - a proven and rapidly expanding therapeutic modality for human diseases. Protein Cell 2010;1:319-330. [PMID: 21203944 PMCID: PMC4875100 DOI: 10.1007/s13238-010-0052-8] [Citation(s) in RCA: 41] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2010] [Accepted: 03/31/2010] [Indexed: 12/19/2022]  Open
13
Eibl MM. History of immunoglobulin replacement. Immunol Allergy Clin North Am 2009;28:737-64, viii. [PMID: 18940572 DOI: 10.1016/j.iac.2008.06.004] [Citation(s) in RCA: 75] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
14
Wang EEL, Tang NK. WITHDRAWN: Immunoglobulin for preventing respiratory syncytial virus infection. Cochrane Database Syst Rev 2007;2006:CD001725. [PMID: 17636681 PMCID: PMC10759784 DOI: 10.1002/14651858.cd001725.pub2] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
15
Lambert PH, Liu M, Siegrist CA. Can successful vaccines teach us how to induce efficient protective immune responses? Nat Med 2005;11:S54-62. [PMID: 15812491 DOI: 10.1038/nm1216] [Citation(s) in RCA: 136] [Impact Index Per Article: 7.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
16
Lacaze-Masmonteil T, Truffert P, Pinquier D, Daoud P, Goldfarb G, Vicaut E, Fauroux B. Lower respiratory tract illness and RSV prophylaxis in very premature infants. Arch Dis Child 2004;89:562-7. [PMID: 15155404 PMCID: PMC1719950 DOI: 10.1136/adc.2003.028282] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
17
Grimaldi M, Cornet B, Milou C, Gouyon JB. [Prospective regional study of an epidemic of respiratory syncytial virus (RSV) bronchiolitis]. Arch Pediatr 2002;9:572-80. [PMID: 12108310 DOI: 10.1016/s0929-693x(01)00923-x] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
18
Sánchez PJ. Immunoprophylaxis for respiratory syncytial virus. Pediatr Infect Dis J 2002;21:473-8. [PMID: 12150195 DOI: 10.1097/00006454-200205000-00036] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
19
Yoo EM, Chintalacharuvu KR, Penichet ML, Morrison SL. Myeloma expression systems. J Immunol Methods 2002;261:1-20. [PMID: 11861062 DOI: 10.1016/s0022-1759(01)00559-2] [Citation(s) in RCA: 43] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
20
Ngai P, Bye MR. Bronchiolitis. Pediatr Ann 2002;31:90-7. [PMID: 11862728 DOI: 10.3928/0090-4481-20020201-06] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
21
Danés Carreras I, Arnau de Bolós J. Profilaxis de las infecciones por el virus respiratorio sincitial con palivizumab. An Pediatr (Barc) 2002. [DOI: 10.1016/s1695-4033(02)77804-1] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]  Open
22
Puigventós Latorre F. [New drugs of year 2000: the challenges of the clinic and the manager]. Med Clin (Barc) 2001;116:465-8. [PMID: 11333707 DOI: 10.1016/s0025-7753(01)71871-4] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
23
Passive immunity in prevention and treatment of infectious diseases. Clin Microbiol Rev 2000. [PMID: 11023960 DOI: 10.1128/cmr.13.4.602-614.2000] [Citation(s) in RCA: 149] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
24
Keller MA, Stiehm ER. Passive immunity in prevention and treatment of infectious diseases. Clin Microbiol Rev 2000;13:602-14. [PMID: 11023960 PMCID: PMC88952 DOI: 10.1128/cmr.13.4.602] [Citation(s) in RCA: 174] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
25
Pringle CR. Prevention of bronchiolitis. Paediatr Respir Rev 2000;1:228-34. [PMID: 12531084 DOI: 10.1053/prrv.2000.0053] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
26
Gern JE, Busse WW. The role of viral infections in the natural history of asthma. J Allergy Clin Immunol 2000;106:201-12. [PMID: 10932062 DOI: 10.1067/mai.2000.108604] [Citation(s) in RCA: 76] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
27
Sawyer LA. Antibodies for the prevention and treatment of viral diseases. Antiviral Res 2000;47:57-77. [PMID: 10996394 DOI: 10.1016/s0166-3542(00)00111-x] [Citation(s) in RCA: 105] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
28
Sánchez PJ. Immunoprophylaxis of respiratory syncytial virus disease. Pediatr Infect Dis J 2000;19:791-801; discussion 802-4. [PMID: 10959760 DOI: 10.1097/00006454-200008000-00033] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
29
Carbonell-Estrany X, Quero J, Bustos G, Cotero A, Doménech E, Figueras-Aloy J, Fraga JM, García LG, García-Alix A, Del Río MG, Krauel X, Sastre JB, Narbona E, Roqués V, Hernández SS, Zapatero M. Rehospitalization because of respiratory syncytial virus infection in premature infants younger than 33 weeks of gestation: a prospective study. IRIS Study Group. Pediatr Infect Dis J 2000;19:592-7. [PMID: 10917214 DOI: 10.1097/00006454-200007000-00002] [Citation(s) in RCA: 104] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
30
Faverge B, Bonein M, Attou D, Benskhria S, Gratecos L. [Prevention of respiratory syncytial virus infection in a peripheral hospital: economic problems and ethical questions]. Arch Pediatr 2000;7:429. [PMID: 10793937 DOI: 10.1016/s0929-693x(00)88845-4] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
31
Antecedentes perinatales y hospitalización por bronquiolitis. Comparación con el Impact-RSV Study Group. An Pediatr (Barc) 2000. [DOI: 10.1016/s1695-4033(00)77494-7] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]  Open
32
Wang EE, Tang NK. Immunoglobulin for preventing respiratory syncytial virus infection. Cochrane Database Syst Rev 2000:CD001725. [PMID: 10796658 DOI: 10.1002/14651858.cd001725] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
33
Green LL. Antibody engineering via genetic engineering of the mouse: XenoMouse strains are a vehicle for the facile generation of therapeutic human monoclonal antibodies. J Immunol Methods 1999;231:11-23. [PMID: 10648924 DOI: 10.1016/s0022-1759(99)00137-4] [Citation(s) in RCA: 114] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
34
Prober CG, Sullender WM. Advances in prevention of respiratory syncytial virus infections. J Pediatr 1999;135:546-58. [PMID: 10547241 DOI: 10.1016/s0022-3476(99)70051-x] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
35
Casadevall A. Passive antibody therapies: progress and continuing challenges. Clin Immunol 1999;93:5-15. [PMID: 10497006 DOI: 10.1006/clim.1999.4768] [Citation(s) in RCA: 65] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
36
Joffe S, Escobar GJ, Black SB, Armstrong MA, Lieu TA. Rehospitalization for respiratory syncytial virus among premature infants. Pediatrics 1999;104:894-9. [PMID: 10506231 DOI: 10.1542/peds.104.4.894] [Citation(s) in RCA: 100] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]  Open
37
Joffe S, Ray GT, Escobar GJ, Black SB, Lieu TA. Cost-effectiveness of respiratory syncytial virus prophylaxis among preterm infants. Pediatrics 1999;104:419-27. [PMID: 10469764 DOI: 10.1542/peds.104.3.419] [Citation(s) in RCA: 146] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]  Open
38
Linehan JM. Respiratory syncytial virus: understanding the threat to communities. JOURNAL OF THE AMERICAN ACADEMY OF NURSE PRACTITIONERS 1999;11:357-63; quiz 364-6. [PMID: 10692709 DOI: 10.1111/j.1745-7599.1999.tb00593.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
39
Canfield SD, Simoes EA. Prevention of respiratory syncytial virus (RSV) infection: RSV immune globulin intravenous and palivizumab. (American Academy of Pediatrics). Pediatr Ann 1999;28:507-14. [PMID: 10483596 DOI: 10.3928/0090-4481-19990801-08] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
40
Sandritter T. Palivizumab for respiratory syncytial virus prophylaxis. J Pediatr Health Care 1999;13:191-5; quiz 196-7. [PMID: 10690084 DOI: 10.1016/s0891-5245(99)90039-1] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
41
Meissner HC, Welliver RC, Chartrand SA, Law BJ, Weisman LE, Dorkin HL, Rodriguez WJ. Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: a consensus opinion. Pediatr Infect Dis J 1999;18:223-31. [PMID: 10093942 DOI: 10.1097/00006454-199903000-00004] [Citation(s) in RCA: 83] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
42
Moler FW, Brown RW, Faix RG, Gilsdorf JR. Comments on palivizumab (Synagis). Pediatrics 1999;103:495-7. [PMID: 9925848 DOI: 10.1542/peds.103.2.495] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]  Open
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA